Bayer (Radiology)

What they make

1 input Bayer (Radiology) supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

• Substitution2024

  The "dye" injected for an MRI is built around a genuinely toxic heavy metal — gadolinium, a rare-earth element — made safe only by tightly wrapping each atom in a chelating molecule so the body can excrete it intact. Bayer is a leading maker of these gadolinium-based agents (Gadavist/gadobutrol). The safety story drove a quiet but important material shift: evidence that gadolinium could be released and retained in the body — causing a serious disease (nephrogenic systemic fibrosis) in patients with poor kidney function, and depositing in the brain — pushed regulators and radiologists away from older, less stable "linear" agents toward more stable "macrocyclic" ones like Bayer's, and prompted FDA warnings. So the MRI contrast in millions of scans is a regulated, safety-evolving product whose chemistry was reformulated in response to the discovery that a toxic injected metal wasn't always leaving the body. And like all rare earths, gadolinium's upstream supply is concentrated (heavily in China), adding a strategic-materials dimension to a routine diagnostic injection. [verify: Gadolinium toxicity, macrocyclic shift, NSF, brain retention, FDA warnings all confirmed]

  Bayer AG (Radiology) ↗

• Did you know2024

  The company that makes the contrast dye for your MRI also makes the chemical that may have been sprayed on the crops in your dinner. Bayer's radiology unit — contrast agents (Ultravist, Gadavist) and the Medrad injectors that pump them into patients — is one small arm of Bayer AG, a sprawling group most famous for pharmaceuticals and consumer health (it invented aspirin) and, since acquiring Monsanto, for crop science: Roundup (glyphosate) herbicide and genetically engineered seeds. So a single German conglomerate spans the MRI dye in a hospital, the aspirin and vitamins in a medicine cabinet, and the herbicide and seeds on a farm — three categories with nothing in common to a consumer, plus the enormous legal overhang of Roundup cancer litigation that came with Monsanto. It's one of the widest and most legally fraught corporate spans in this radar, and a reminder that the contrast injected for a diagnosis and the chemistry sprayed on agriculture can sit inside the very same company.

  Bayer AG ↗

• Concentration2024

  Bayer rounds out the tight contrast-media oligopoly — GE HealthCare, Bayer, Bracco and Guerbet — that supplies nearly all of the iodinated and gadolinium agents diagnostic imaging depends on, and it adds a second lock-in through its Medrad power injectors. The injectors and the contrast form a razor-and-blades pairing: hospitals that install a particular injector system are nudged toward compatible contrast and consumables, deepening the supplier relationship beyond the dye itself. Combined with the underlying dependence on scarce inputs (iodine from two countries, gadolinium from China-dominated rare-earth supply) and on a few fill-finish plants, the imaging-contrast business shows the same multi-layer fragility seen across medical supply in this radar: a handful of manufacturers, a couple of feedstock geographies, and equipment lock-in all stacked beneath a procedure — the contrast scan — that modern medicine treats as routine.

  Bayer AG (Radiology) ↗